November 16, 2023 VCP Disease(s), an Integrated Approach to Neurodegenerative Disorders In this webinar from Critical Path Institute’s Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP), speake
November 9, 2023 C-Path’s Pioneering Neuroscience Workshop Transforms the Landscape of Neurological Disorder Therapies TUCSON, Ariz., Nov. 9, 2023 – Critical Path Institute (C-Path) is pleased to announce the release of a new peer-reviewed publica
November 30, 2023 2023 C-Path Neuroscience Annual Meeting C-Path’s 2023 Neuroscience Program Annual Meeting is set for Thursday, November 30 in Washington D.C. Bringing stakeholders....
C-Path Partners with Unite4TB to Create a New Dawn in the Fight Against Tuberculosis C-Path is proud to be part of UNITE4TB, a public-private partnership funded by the Innovative Medicines Initiative and part of the
November 7, 2023 C-Path’s T1D Consortium New-onset Article Published in The Lancet Diabetes and Endocrinology ype 1 Diabetes Consortium, along with external collaborators from Cardiff University and the University of Alberta, today announce
eCOA Consortium Announces Publication of an Open Access Article C-Path’s eCOA Consortium is pleased to announce the publication of an open access article in Value in Health titled “Best Prac
October 26, 2023 C-Path and Congenital Hyperinsulinism International Announce Data Sharing Agreement TUCSON, Ariz., October 26, 2023 — Critical Path Institute (C-Path) and Congenital Hyperinsulinism International (CHI), a leading
October 25, 2023 C-Path Announces Significant Expansion in Neonatal RWD Project Details of the expansion will be a highlight of the Institute’s Scientific Breakthrough Summit Oct. 26-27 in D.C. TUCSON, Ariz.,
November 21, 2023 Use of Registries in Regulatory Decision Making The C-Path team is working to revolutionize the use of real-world data in sharing the future of medical product development in...